(Q40518414)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15351977%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

title

Detection of residual neuroblastoma cells in bone marrow: comparison of flow cytometry with immunocytochemistry (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15351977%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

1 reference

1 reference

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15351977%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

author name string

Katrien Swerts

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15351977%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Barbara De Moerloose

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15351977%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Catharina Dhooge

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15351977%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Bénédicte Brichard

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15351977%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Yves Benoit

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15351977%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Geneviève Laureys

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15351977%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

publication date

1 September 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15351977%20AND%20SRC:MED&resulttype=core&format=json

Cytometry Part B: Clinical Cytometry

1 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15351977%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

volume

61

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15351977%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15351977%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

page(s)

9-19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15351977%20AND%20SRC:MED&resulttype=core&format=json

Quantitative tumor cell content of bone marrow and blood as a predictor of outcome in stage IV neuroblastoma: a Children's Cancer Group Study.

1 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20019

Disease outcome may be predicted by molecular detection of minimal residual disease in bone marrow in advanced neuroblastoma: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20019

Outcome prediction by molecular detection of minimal residual disease in bone marrow for advanced neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20019

Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20019

Detection of micrometastasis of neuroblastoma to bone marrow and tumor dissemination to hematopoietic autografts using flow cytometry and reverse transcriptase-polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20019

Unequivocal identification of disseminated tumor cells in the bone marrow by combining immunological and genetic approaches--functional and prognostic information.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20019

Circulating neuroblastoma cells detected by reverse transcriptase polymerase chain reaction for tyrosine hydroxylase mRNA are an independent poor prognostic indicator in stage 4 neuroblastoma in children over 1 year

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20019

Detecting disseminated solid tumor cells in hematopoietic samples: methodological aspects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20019

Flow cytometric immunophenotyping test for staging/monitoring neuroblastoma patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20019

Quantitative analysis of tyrosine hydroxylase mRNA for sensitive detection of neuroblastoma cells in blood and bone marrow

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20019

Detection of neuroblastoma cells in bone marrow using GD2 specific monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20019

Advances in the immunological monitoring of childhood acute lymphoblastic leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20019

1070 myeloablative megatherapy procedures followed by stem cell rescue for neuroblastoma: 17 years of European experience and conclusions. European Group for Blood and Marrow Transplant Registry Solid Tumour Working Party

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20019

7 January 2021

Prognostic significance of GAGE detection in bone marrows on survival of patients with metastatic neuroblastoma

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20019

7 January 2021

Detection of metastatic neuroblastoma in bone marrow: when is routine marrow histology insensitive?

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20019

7 January 2021

Flow cytometric analysis of peripheral blood and bone marrow for tumor cells in patients with neuroblastoma

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20019

7 January 2021

A new sensitive and specific combination of CD81/CD56/CD45 monoclonal antibodies for detecting circulating neuroblastoma cells in peripheral blood using flow cytometry

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20019

7 January 2021

Differential expression of leukocyte differentiation antigens in small round blue cell sarcomas.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20019

7 January 2021

TAPA-1, the target of an antiproliferative antibody, defines a new family of transmembrane proteins

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20019

7 January 2021

Characterization of neural cell adhesion molecules (NCAM) expressed by Ewing and neuroblastoma cell lines

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20019

7 January 2021

Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes)

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20019

7 January 2021

In vivo cytoreduction studies and cell sorting--enhanced tumor-cell detection in high-risk neuroblastoma patients: implications for leukapheresis strategies

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20019

7 January 2021

N7: a novel multi-modality therapy of high risk neuroblastoma (NB) in children diagnosed over 1 year of age.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20019

7 January 2021

Prognostic value of immunocytologic detection of bone marrow metastases in neuroblastoma

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20019

7 January 2021

Monoclonal antibodies for detecting bone marrow invasion by neuroblastoma

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20019

7 January 2021